Pharvaris
Price & Volume
Stats
See moreOpen | $36.40 |
Previous Close | $37.23 |
Day Range | $36.24-$37.33 |
52W Range | $20.65-$38.13 |
Market Cap | $2.6B |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.12 |
News
See moreYahoo Finance • 20 days ago
Claude AI’s Newest Stock Picks Are Also Hedge Fund Favorites: One Breakout Biotech, One AI Chip Bet
Yahoo Finance • last month
After a 96% 1-Year Run, This Director Sold 37,600 PHVS Shares for $1.3 Million. Is the Rally Over?
Yahoo Finance • last month
Publication in Clinical Reviews in Allergy & Immunology Summarizes Decades of Evidence Supporting Bradykinin B2 Receptor as a Validated Therapeutic Target in Bradykinin-Mediated Angioedema
Yahoo Finance • 3 months ago
What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors
About
CEO | Mr. Berndt Axel Edvard Modig CPA, M.B.A. |
CFO | Mr. David W. Nassif J.D. |
Address | Grafenauweg 8, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 148 |